OPTIMISE IME LIMITED

Dissolved London

Other information technology service activities

2 employees website.com
Other information technology service activities
O

OPTIMISE IME LIMITED

Other information technology service activities

Founded 17 Jun 2016 Dissolved London, United Kingdom 2 employees website.com
Other information technology service activities

Previous Company Names

OPTIMISE PHARMA LIMITED 17 Jun 2016 — 25 May 2022
Accounts Submitted 29 Aug 2025 Next due 29 Aug 2025 10 months overdue
Confirmation Submitted 17 Oct 2024 Next due 26 Oct 2025 8 months overdue
Net assets £-2K £204 2024 year on year
Total assets £120K £205 2024 year on year
Total Liabilities £121K £1 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

26 Market Place London W1W 8AW United Kingdom

Full company profile for OPTIMISE IME LIMITED (10236803), a dissolved company based in London, United Kingdom. Incorporated 17 Jun 2016. Other information technology service activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Dec → 30 Nov 2024
Type total-exemption-full
Next accounts 29 Nov 2024
Due by 29 Aug 2025 10 months overdue

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£3.00

Decreased by £204.00 (-99%)

Net Assets

-£1.58k

Decreased by £204.00 (-15%)

Total Liabilities

£121.13k

Decreased by £1.00 (-0%)

Turnover

N/A

Employees

2

Debt Ratio

101%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Nov Year End
2023
30 Nov Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Nexgen Healthcare Communications LimitedCorporate-directorUnknownUnknown17 Jun 2016Active

Shareholders

Shareholders (1)

Nexgen Healthcare Communications Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Notified 17 Jun 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Incuna Ltd

Ceased 12 Oct 2017

Ceased
Ceased

Group Structure

Group Structure

OPTIMISE IME LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Mar 2026GazetteGazette Dissolved Compulsory
26 Sept 2025OfficersChange Corporate Director Company With Change Date
29 Aug 2025AccountsAnnual accounts made up to 30 Nov 2024
17 Oct 2024Confirmation StatementConfirmation statement made on 12 Oct 2024 with no updates
29 Aug 2024AccountsAnnual accounts made up to 30 Nov 2023
24 Mar 2026 Gazette

Gazette Dissolved Compulsory

26 Sept 2025 Officers

Change Corporate Director Company With Change Date

29 Aug 2025 Accounts

Annual accounts made up to 30 Nov 2024

17 Oct 2024 Confirmation Statement

Confirmation statement made on 12 Oct 2024 with no updates

29 Aug 2024 Accounts

Annual accounts made up to 30 Nov 2023

Recent Activity

Latest Activity

Gazette Dissolved Compulsory

2 months ago on 24 Mar 2026

Change Corporate Director Company With Change Date

8 months ago on 26 Sept 2025

Annual accounts made up to 30 Nov 2024

9 months ago on 29 Aug 2025

Confirmation statement made on 12 Oct 2024 with no updates

1 years ago on 17 Oct 2024

Annual accounts made up to 30 Nov 2023

1 years ago on 29 Aug 2024